1932

Abstract

Abstract

Lack of adipose tissue, either complete or partial, is the hallmark of disorders known as lipodystrophies. Patients with lipodystrophies suffer from metabolic complications similar to those associated with obesity, including insulin resistance, type 2 diabetes, hypertriglyceridemia, and hepatic steatosis. The loss of body fat in inherited lipodystrophies can be caused by defects in the development and/or differentiation of adipose tissue as a consequence of mutations in a number of genes, including (encoding a nuclear hormone receptor), (encoding an enzyme involved in the biosynthesis of triglyceride and phospholipids), (encoding a protein involved in insulin signal transduction), and (encoding seipin, whose role in the adipocyte biology remains unclear). The loss of body fat can also be caused by the premature death of adipocytes due to mutations in lamin A/C, nuclear lamina proteins, and ZMPSTE24, which modifies the prelamin A post-translationally. In this review, we focus on the molecular basis of inherited lipodystrophies as they relate to adipocyte biology and their associated phenotypic manifestations.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.genom.7.080505.115715
2006-09-22
2024-06-20
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.genom.7.080505.115715
Loading
/content/journals/10.1146/annurev.genom.7.080505.115715
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error